|
|
???tair.name??? >
???browser.page.title.author???
|
"lu s"???jsp.browse.items-by-author.description???
Showing items 16-25 of 95 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-02-07T03:29:02Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang Y.; Lu L.-C.; Guan Y.; Ho M.-C.; Lu S.; Spahn J.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-01-25T05:10:40Z |
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|
CHI-LING CHEN; Yang HwaiI.; Yang W.; Liu C.; Chen P.; You S.; Wang L.; Sun C.; Lu S.; Chen D.; Chen C. |
| 臺大學術典藏 |
2022-01-25T05:10:37Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2022-01-24T09:32:08Z |
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|
Chen C.; Yang HwaiI.; Yang W.; CHUN-JEN LIU; Chen P.; You S.; Wang L.; Sun C.; Lu S.; Chen D.; Chen C. |
| 臺大學術典藏 |
2022-01-24T09:32:02Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
CHUN-JEN LIU; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 國立成功大學 |
2022 |
Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC
|
Wu, Y.-L.;Lu, S.;Yang, J.C.-H.;Zhou, J.;Seto, T.;Ahn, M.-J.;Su, W.-C.;Yamamoto, N.;Kim, D.-W.;Paolini, J.;Usari, T.;Iadeluca, L.;Wilner, K.D.;Goto, K. |
| 國立成功大學 |
2022 |
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
|
Lu, S.;Wang, Q.;Zhang, G.;Dong, X.;Yang, C.-T.;Song, Y.;Chang, G.-C.;Lu, Y.;Pan, H.;Chiu, Chiu C.-H.;Wang, Z.;Feng, J.;Zhou, J.;Xu, Xu X.;Guo, R.;Chen, J.;Yang, H.;Chen, Y.;Yu, Z.;Shiah, H.-S.;Wang, C.-C.;Yang, N.;Fang, J.;Wang, P.;Wang, K.;Hu, Y.;He, J.;Wang, Z.;Shi, J.;Chen, S.;Wu, Q.;Sun, C.;Li, C.;Wei, H.;Cheng, Y.;Su, W.-C.;Hsia, T.-C.;Cui, J.;Sun, Y.;Ou, S.-H.I.;Zhu, V.W.;Chih-Hsin, Yang J. |
| 臺大學術典藏 |
2021-09-15T06:19:22Z |
Relationship between renal function and metal exposure of residents living near the No. 6 Naphtha Cracking Complex: A cross-sectional study
|
Yuan T.-H.; Jhuang M.-J.; Yeh Y.-P.; Chen Y.-H.; Lu S.; CHANG-CHUAN CHAN |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-09-02T00:04:51Z |
Application of zadoff-chu sequences in throughput balancing control of self-organizing long term evolution communication network
|
Lu S;Lee Y.-H;Chen Y.-L;Tseng H.-W;Chen C.-C;Chen J.-H;Tsao H.-W;Wu J.-S.; Lu S; Lee Y.-H; Chen Y.-L; Tseng H.-W; Chen C.-C; Chen J.-H; Tsao H.-W; Wu J.-S.; HEN-WAI TSAO |
Showing items 16-25 of 95 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
